Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Oct;89(2):299-305.
doi: 10.1111/j.1476-5381.1986.tb10260.x.

Pressure reversal of alphaxalone/alphadolone and methohexitone in tadpoles: evidence for different molecular sites for general anaesthesia

Pressure reversal of alphaxalone/alphadolone and methohexitone in tadpoles: evidence for different molecular sites for general anaesthesia

M J Halsey et al. Br J Pharmacol. 1986 Oct.

Abstract

Tadpoles were used to study quantitative interactions between high pressure and two intravenous anaesthetics, alphaxalone/alphadolone and methohexitone. The potencies of the two agents were decreased by high pressure but to different extents. The maximum effect was seen in the pressure range 70-130 atmospheres absolute (ATA). The increases in the normobaric anaesthetizing concentration (ED50) required at 100 ATA were alphaxalone/alphadolone:405 +/- 5 (s.d.)%; methohexitone:658 +/- 80 (s.d.)%. For both alphaxalone/alphadalone and methohexitone, the curves obtained when the increase in ED50 was plotted against increasing pressure showed plateaux at pressures above 70 ATA. These data support the concept of the two intravenous drugs causing general anaesthesia by the occupation of separate molecular 'sites' with different but finite capacities.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Anaesth. 1981 Jun;53(6):577-84 - PubMed
    1. Br J Anaesth. 1978 Nov;50(11):1091-7 - PubMed
    1. Br J Pharmacol. 1981 Sep;74(1):161-70 - PubMed
    1. Physiol Rev. 1982 Oct;62(4 Pt 1):1341-77 - PubMed
    1. Br J Pharmacol. 1982 Nov;77(3):493-504 - PubMed